Strax

Autospela

CAR T-Cell Therapy for Relapsed/Refractory CLL

2 Visningar • 07/14/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

The panelists provide insight on the use of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia and the TRANSCEND CLL-004 trial of liso-cel (JCAR017) in relapsed/refractory disease.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela